Skip to main content

Covista Inc. (CVSA) Stock Analysis

Range Bound setup

HoldModerate Confidence

Consumer Defensive · Education & Training Services

Earnings in 7 days (2026-05-07). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Hold if already holding. Not a fresh buy at $114.79, but acceptable to hold if already in. Reasons: Earnings in 7 days (event risk); Below 200-MA, MA slope -1.2%/30d (confirmed downtrend).

Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse talent workforce that meets the needs of the healthcare industry. The purpose of Adtalem is to empower students to achieve their goals, find success, and make... Read more

$114.79+13.9% A.UpsideScore 5.6/10#7 of 15 Education & Training Services
Stop $107.01Target $130.69(analyst − 15%)A.R:R 1.7:1
Analyst target$153.75+33.9%4 analysts
$130.69our TP
$114.79price
$153.75mean
$175

Hold if already holding. Not a fresh buy at $114.79, but acceptable to hold if already in. Reasons: Earnings in 7 days (event risk); Below 200-MA, MA slope -1.2%/30d (confirmed downtrend). Chart setup: RSI 55 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Score 5.6/10, moderate confidence.

Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 7d<=7d. Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (4/4)
Attractive valuation
Risks
Earnings in 7 days (event risk)
Below 200-MA, MA slope -1.2%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)16.9
P/E (Fwd)13.1
Mkt Cap$4.0B
EV/EBITDA10.8
Profit Mgn13.4%
ROE18.0%
Rev Growth12.4%
Beta0.63
DividendNone
Rating analysts10

Quality Signals

Piotroski F8/9

Options Flow

P/C0.73neutral
IV77%elevated

Material Events(8-K, last 90d)

  • 2026-03-03Item 1.02MEDIUM
    **Delaware** | **001-13988** | **36-3150143** (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | | **233 South Wacker Drive** **Chicago****,****IL** | | **60606** (Address of principal executive offices) | | (Zip Code) ​ **(****312****)...
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesMomentum 4.1<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 7d<=7dA.R:R 1.7 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
55 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $105.67Resistance $119.23

Price Targets

$107
$131
A.Upside+13.9%
A.R:R1.7:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Momentum score 4.1/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA
! EARNINGS_PROXIMITY:7d<=7d

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-05-07 (7d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CVSA stock a buy right now?

Hold if already holding. Not a fresh buy at $114.79, but acceptable to hold if already in. Reasons: Earnings in 7 days (event risk); Below 200-MA, MA slope -1.2%/30d (confirmed downtrend). Chart setup: RSI 55 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Target $130.69 (+13.9%), stop $107.01 (−7.3%), A.R:R 1.7:1. Score 5.6/10, moderate confidence.

What is the CVSA stock price target?

Take-profit target: $130.69 (+13.9% upside). Target $130.69 (+13.9%), stop $107.01 (−7.3%), A.R:R 1.7:1. Stop-loss: $107.01.

What are the risks of investing in CVSA?

Earnings in 7 days (event risk); Below 200-MA, MA slope -1.2%/30d (confirmed downtrend).

Is CVSA overvalued or undervalued?

Covista Inc. trades at a P/E of 16.9 (forward 13.1). TrendMatrix value score: 7.4/10. Verdict: Hold.

What do analysts say about CVSA?

10 analysts cover CVSA with a consensus score of 4.3/5. Average price target: $154.

What does Covista Inc. do?Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse...

Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse talent workforce that meets the needs of the healthcare industry. The purpose of Adtalem is to empower students to achieve their goals, find success, and make inspiring contributions to our global community.

Related stocks: LAUR (Laureate Education, Inc.) · TAL (TAL Education Group) · PRDO (Perdoceo Education Corporation) · EDU (New Oriental Education & Techno) · COUR (Coursera, Inc.)